Fairmount Funds Management LLC 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-01 6:34 pm Sale |
2024-04-01 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 2,957,385 9.990% |
-3,362 (-0.11%) |
Filing |
| 2024-01-24 5:26 pm Purchase |
2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 2,960,747 9.900% |
1,086,914 (+58.00%) |
Filing |
| 2023-09-21 4:32 pm Purchase |
2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 1,873,833 12.700% |
1,873,833 (New Position) |
Filing |